CG Oncology, Inc. Common stock Cash Flow
Concept
Operating Cash Flow
Net Income
Depreciation & Amortization
Stock based compensation
Other non cash items
Change in working capital
Investing Cash Flow
Capital Expenditures
Financing Cash Flow
Dividends Paid
Payout Ratio
Share Issuance / Repurchase
Debt Issued / Paid
Other Investing Activities
End Cash Position
Changes in Cash
Beginning Cash Position
Free Cash Flow
2023
2022
2021
-46M
-49M
0M
2M
1M
3M
-121M
0M
87M
0M
-0 %
0M
0M
0M
8M
-80M
88M
-46M
-30M
-35M
0M
1M
1M
4M
-55M
0M
120M
0M
-0 %
0M
0M
0M
88M
35M
54M
-30M
-14M
-13M
0M
1M
0M
-2M
0M
0M
15M
0M
-0 %
0M
0M
0M
54M
2M
52M
-14M
Concept
Operating Cash Flow
Net Income
Depreciation & Amortization
Stock based compensation
Other non cash items
Change in working capital
Investing Cash Flow
Capital Expenditures
Financing Cash Flow
Dividends Paid
Payout Ratio
Share Issuance / Repurchase
Debt Issued / Paid
Other Investing Activities
End Cash Position
Changes in Cash
Beginning Cash Position
Free Cash Flow
4Q2023
4Q2022
-16M
-16M
0M
1M
0M
2M
17M
0M
-3M
0M
-0 %
0M
0M
0M
8M
-2M
10M
-16M
-7M
-8M
0M
0M
0M
1M
-55M
0M
57M
0M
-0 %
0M
0M
0M
88M
-5M
94M
-7M